Uranium has reentered the spotlight amid fresh commitments to nuclear power expansion, energy security priorities, and ongoing supply constraints. Investors looking for exposure often turn to the two leading options: the Global X Uranium ETF (URA) and the Sprott Uranium Miners ETF (URNM). While both track the uranium theme, their approaches differ in meaningful ways. URA spreads exposure across the broader nuclear value chain, whereas URNM stays tightly focused on miners and physical uranium holdings. I examined their structures, fees, and positioning to see which might better align with different investor needs.
The Global X Uranium ETF (URA) tracks the Solactive Global Uranium & Nuclear Components Total Return Index and has been available since November 2010. It holds approximately 50–60 securities that cover uranium mining, exploration, refining, and nuclear equipment manufacturing. Top positions include CCJ (Cameco), Sprott Physical Uranium Trust, NexGen Energy (NXE), OKLO (Oklo), NAC Kazatomprom, UEC (Uranium Energy), and LEU (Centrus Energy). Energy accounts for roughly 60–66% of the fund, with industrials making up another 22–29%, giving it exposure to nuclear-component producers and related firms. The expense ratio stands at 0.69%, and its larger size supports strong liquidity.
The Sprott Uranium Miners ETF (URNM) follows the VettaFi Global Uranium Mining Index and launched in December 2019, with a reorganization under Sprott in 2022. It targets companies deriving at least 50% of assets from uranium mining and holds about 22–26 issuers. Roughly 80–84% of assets sit in uranium equities and 16–20% in physical uranium. Major holdings feature CCJ (Cameco), Sprott Physical Uranium Trust, NexGen Energy (NXE), CGN Mining, NAC Kazatomprom, Yellow Cake plc, UEC (Uranium Energy), DNN (Denison Mines), and UUUU (Energy Fuels). Its 0.75% expense ratio reflects the more concentrated, higher-beta design.
Both ETFs operate against a backdrop of structural supply shortfalls and growing demand. Government pledges to triple nuclear capacity, reactor restarts, and energy-independence goals continue to tighten the supply picture. Producers like Cameco and Kazatomprom navigate long-term contracting, while physical trusts absorb available material. Emerging small modular reactor developers add another layer of interest. Risks such as regulatory changes, financing hurdles, and geopolitical factors around Kazakh supply remain relevant and can influence both funds differently based on their structures. I also checked this using Tickeron’s AI Screener to see how the funds compare on relative strength metrics.
Both ETFs have tracked uranium price moves and shared holdings closely in recent periods. URNM’s concentrated pure-play approach and physical uranium allocation tend to amplify swings when sentiment shifts. URA’s mix of miners with industrial and nuclear-component names provides some offset during weaker commodity periods while still participating in strong rallies. URA’s lower 0.69% expense ratio and larger asset base give it an edge on cost and liquidity, while URNM suits those wanting maximum direct exposure to uranium prices.
One resource I turn to regularly is Tickeron’s AI Screener. It helps filter securities by technical patterns, fundamentals, volatility, and custom criteria, making it easier to compare ETFs like these side by side without manual effort. The tool has proven useful for spotting relative trends and refining ideas around thematic exposure.
Based on the structural details, Tickeron’s AI currently points toward URA over URNM. The lower expense ratio, wider diversification across 50–60 holdings, stronger liquidity, and more balanced sector exposure support steadier risk-adjusted results across cycles. URNM still appeals to those seeking concentrated, unhedged uranium and physical exposure with greater sensitivity to spot prices. Overall, URA presents the more resilient profile on cost, diversification, and liquidity, while URNM serves as a higher-beta option for stronger uranium conviction.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
URA saw its Momentum Indicator move below the 0 level on October 29, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 84 similar instances where the indicator turned negative. In 78 of the 84 cases, the stock moved further down in the following days. The odds of a decline are at 90%.
The Moving Average Convergence Divergence Histogram (MACD) for URA turned negative on November 17, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In 38 of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at 88%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where URA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for URA entered a downward trend on November 18, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +10.85% 3-day Advance, the price is estimated to grow further. Considering data from situations where URA advanced for three days, in 304 of 325 cases, the price rose further within the following month. The odds of a continued upward trend are 90%.
URA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows